Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: Results of integrated analyses of data from phase II and III clinical studies

K. Reich, R. G. Langley, M. Lebwohl, P. Szapary, C. Guzzo, N. Yeilding, S. Li, M. C. Hsu, Christopher E M Griffiths

    Research output: Contribution to journal › Article › peer-review

    Fingerprint

    Dive into the research topics of 'Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: Results of integrated analyses of data from phase II and III clinical studies'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science